Cargando…

Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade

Treatment with immune checkpoint inhibitors has altered the course of malignant melanoma, with approximately half of the patients with advanced disease surviving for more than 5 years after diagnosis. Currently, there are no biomarker methods for predicting outcome from immunotherapy. Here, we obtai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vathiotis, Ioannis A., Salichos, Leonidas, Martinez-Morilla, Sandra, Gavrielatou, Niki, Aung, Thazin Nwe, Shafi, Saba, Wong, Pok Fai, Jessel, Shlomit, Kluger, Harriet M., Syrigos, Konstantinos N., Warren, Sarah, Gerstein, Mark, Rimm, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755314/ https://www.ncbi.nlm.nih.gov/pubmed/36522538 http://dx.doi.org/10.1038/s41698-022-00330-3

Ejemplares similares

Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma
por: Gavrielatou, Niki, et al.
Publicado: (2023)

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer
por: MacNeil, Tyler, et al.
Publicado: (2021)

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
por: Aung, Thazin Nwe, et al.
Publicado: (2022)

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2023)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2020)

Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non–small Cell Lung Cancer
por: Aung, Thazin N., et al.
Publicado: (2023)

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Spatial characterization and quantification of CD40 expression across cancer types
por: Bates, Katherine M., et al.
Publicado: (2023)

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study
por: Yaghoobi, Vesal, et al.
Publicado: (2021)

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
por: Tsiakos, Konstantinos, et al.
Publicado: (2022)

The Role of B Cells in Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
por: Wong, Pok Fai, et al.
Publicado: (2019)

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
por: Moutafi, Myrto K, et al.
Publicado: (2022)

Estimating growth patterns and driver effects in tumor evolution from individual samples
por: Salichos, Leonidas, et al.
Publicado: (2020)

Genetic determination of regional connectivity in modelling the spread of COVID-19 outbreak for more efficient mitigation strategies
por: Salichos, Leonidas, et al.
Publicado: (2023)

Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action
por: Aung, Thazin Nwe, et al.
Publicado: (2017)

Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma
por: Smithy, James W., et al.
Publicado: (2017)

Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry
por: MacNeil, Tyler, et al.
Publicado: (2020)

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
por: Moutafi, Myrto, et al.
Publicado: (2023)

The Role of Tinzaparin in Oncology
por: Dimakakos, Evangelos P., et al.
Publicado: (2017)

Evaluating Ortholog Prediction Algorithms in a Yeast Model Clade
por: Salichos, Leonidas, et al.
Publicado: (2011)

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma
por: Gupta, Swati, et al.
Publicado: (2019)

CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma?
por: Su, David, et al.
Publicado: (2023)

Tumor Dormancy: Implications for Invasion and Metastasis
por: Gomatou, Georgia, et al.
Publicado: (2021)

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond
por: Vathiotis, Ioannis A., et al.
Publicado: (2023)

Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection
por: Cui, Jian, et al.
Publicado: (2019)

Identification of the miRNAome in human fracture callus and nonunion tissues
por: Hadjiargyrou, Michael, et al.
Publicado: (2023)

STING enhances cell death through regulation of reactive oxygen species and DNA damage
por: Hayman, Thomas J., et al.
Publicado: (2021)

A Genome-Scale Investigation of How Sequence, Function, and Tree-Based Gene Properties Influence Phylogenetic Inference
por: Shen, Xing-Xing, et al.
Publicado: (2016)

CD24: A Novel Target for Cancer Immunotherapy
por: Panagiotou, Emmanouil, et al.
Publicado: (2022)

Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond
por: Lozar, Taja, et al.
Publicado: (2023)

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer
por: Moutafi, Myrto K, et al.
Publicado: (2021)

Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis
por: Shen, Hanyuan, et al.
Publicado: (2019)

The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms
por: Cui, Jian, et al.
Publicado: (2020)

A New Strategy for Identifying Mechanisms of Drug-drug Interaction Using Transcriptome Analysis: Compound Kushen Injection as a Proof of Principle
por: Shen, Hanyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9lr3an8kpbbtcmu3cd6b9dl88m